home About Us People Portfolio News Contact Us Fund I Investor Login » Fund II Investor Login » Fund III Investor Login »


$35 million

Tools & Diagnostics

RainDance Technologies To Be Sold to Bio-Rad »

Billerica, Mass. — January 16, 2017 — RainDance Technologies, a life sciences tools company, announced today that its Board of Directors has entered into a definitive agreement to sell the company to Bio-Rad Laboratories, Inc.


Since its foundation in 2004, RainDance pioneered the development and application of droplet microfluidic technology for biological applications, and in the process built a substantial and foundational patent portfolio in the field. 
RainDance markets products for digital PCR and sample enrichment for Next Generation Sequencing (NGS) and has demonstrated feasibility for use of its droplet technology for digital ELISA, linked read NGS, single cell analysis, compound screening for therapeutics and enzyme evolution.  RainDance’s ThunderStorm®, ThunderBolts™ and RainDrop® products are used in laboratories throughout the world.


About RainDance Technologies


Based outside Boston, Massachusetts, RainDance Technologies offers a proprietary droplet technology that enables research in areas such as non-invasive liquid biopsy. These ultra-sensitive genomic tools that include RainDrop® Digital PCR, ThunderStorm®, and ThunderBolts™ Next-Generation Sequencing Enrichment, offer accurate, reliable, and cost-effective detection of genetic variations in cancer as well as inherited and infectious diseases. RainDance customers include research institutions and laboratories around the world.


RainDance products are for Research Use Only. Not for use in diagnostic procedures.


RainDance Technologies, the RainDance Technologies logo and ThunderStorm, ThunderBolts, and RainDrop are trademarks of RainDance Technologies, Inc. All other brands may be trademarks of their respective holders.

Dec7RainDance Technologies and Blood Systems Research Institute Collaborate to Develop Ultra-sensitive Assays to Detect and Quantify HIV Latency »

May5Pacific Biosciences and RainDance Technologies Partner to Co-Develop and Commercialize Novel Solution For de novo Whole Genome Assembly »

Apr20RainDance Launches ThunderBolts Next-Gen Sequencing Panel to Research Genetic Mutations for Myeloid Malignancies »

Apr16RainDance Technologies Extends Global Commercial Reach with Distributor Appointments in Europe and Middle East »

Feb25RainDance Expands ThunderBolts Portfolio with Launch of Low-Cost, Low-Input Next-Gen Sequencing Enrichment System for Liquid Biopsy »

Mar3RainDance Technologies Closes Series E Financing with GE »

Nov13RainDance RainDrop System Proven to be Industry’s Most Precise Digital PCR Platform for Measuring Chromosomal Copy Number »

Sep23RainDance Technologies Secures $35 Million in Financing from Capital Royalty Partners »